Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK
JNNP 82:646-651, Heath, C.A.,et al, 2011
Recipients of Blood or Blood Products "at vCJD risk"
BMJ 328:118-119, Bird,S.M., 2004
Novel Methods for Disinfection of Prion-Contaminated Medical Devices
Lancet 364:521-526, Fichet,G.,et al, 2004
Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt-Jakob Disease
NEJM 349:1812-1820, Glatzel,M.,et al, 2003
Risk of Acquiring Creutzfeldt-Jakob Disease from Blood Transfusions: Systematic Review of Case-Control Studies
BMJ 321:17-19, Wilson,K. et al, 2000
Surgical Treatment and Risk of Sporadic Creutzfeldt-Jakob Disease:A Case-Control Study
Lancet 353:693-697, Collins,S.,et al, 1999
Transmission ofr Creutzfeldt-Jakob Disease in Corneal Grafts, Exclusion Criteria Ensure Risk is Small
BMJ 315:1553-1554, Allan,B.&Tuft,S., 1997
Potential Transmission of BSE via Medicinal products
BMJ 312:988-989, Wickham,E.A., 1996
Creutzfeldt-Jakob Disease from Contaminated Growth Hormone Extracts in France
Neurol 47:690-695, Billette de Villemeur,T.,et al, 1996
Creutzfeldt-Jakob Disease in a Physician:A Review of the Disorder in Health Care Workers
Neurol 43:205-206, Berger,J.R.&David,N.J., 1993
Creutzfeldt-Jakob Disease in a Pathologist
Neurol 42:463, Gorman,D.G.,et al, 1992
"Friendly Fire"in Medicine:Hormones, Homografts, and Creutzfeldt-Jakob Disease
Lancet 340:24-27, Brown,P.,et al, 1992
Creutzfeldt-Jakob Disease in a Patient with a Cadaveric Dural Graft
Neurol 41:940-941, Miyashita,K.,et al, 1991
A Simple & Effective Method for Inactivating Virus Infectivity from Patients with Creutzfeldt-Jakob Disease
Neurol 40:887-890, Brown,P.,et al, 1990
Routine Use of Phenolized Formalin in Fixation of Autopsy Brain Tissue to Reduce Risk of Inadvert Trans of Creutzfeldt-Jakob Dis
NEJM 319:654, Brumback,R.A., 1988
Precautions in Handling Tissues
Fluids, & Other Contam Materials from Patients with Documented or Suspected Creutzfeldt-Jakob Diseas, , Aeurol 19:75-77,1986., 1986
Sodium Hydroxide Decontamination of Creutzfeldt-Jacob Disease Virus
NEJM 310:727, Brown,P.,et al, 1984
Chemical Disinfection Of Creutzfeldt-Jakob Disease Virus
NEJM 306:1279-1282, Brown,P.,et al, 1982
Transissible Dementias:Current Problems in Tissue Handling
Neurol 30:302-303, Baringer,J.R.,et al, 1980
Precautions in Familial Transmissible Dementia
Arch Neurol 35:697-698, Cook,R.,et al, 1978
Precautions in Medical Care Handling Matrl. of Patients with Transmissible Virus Dementia (Creutzfeldt-Jakob Disease)
NEJM 297:1253, Gajdusek,C.,et al, 1977
More Than a Little Unsteady
NEJM 387:e9, Kraft, A.W.,et al, 2022
Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist
AJNR 42:998-1007, Oldan, J.D.,et al, 2021
Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations
AJNR 37:774-781, Winton-Brown, T.T.,et al, 2016
Evidence-based Guideline: Diagnostic accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease
Neurol 79:1499-1506, Muayqil, T.,et al, 2012
The Evaluation of Rapidly Progressive Dementia
The Neurologist 17:67-74, Rosenbloom,M.H. &Atri,A., 2011
Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Neurol 77:179-189, Lancaster, E.,et al, 2011
Rapidly Progressive Neurodegenerative Dementias
Arch Neurol 66:201-207, Josephs,K.A.,et al, 2009
MRI Lesion Profiles in Sporadic Creutzfeldt-Jakob Disease
Neurol 72:1994-2001, Meissner,B.,et al, 2009
Bilateral Thalamic Lesions
AJR 192:W53-W62, Smith,A.B.,et al, 2009
Systematic Review of Therapeutic Intervention in Human Prion Disease
Neurol 70:1272-1281, Stewart,L.A.,et al, 2008
Transmissible Spongiform Encephalopathy in the 21st Century: Neuroscience for the Clinical Neurologist
Neurol 70:713-722, Brown,P., 2008
Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008
Neuroimaging Findings in Human Prion Disease
JNNP 78:664-670, Macfarlane,R.G.,et al, 2007
Iatrogenic Creutzfeldt-Jakob Disease: The Waning of an Era
Neurol 67:389-393, Brown,P.,et al, 2006
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Psychiatric Manifestations of Creutzfeldt-Jakob Disease: A 25-Year Analysis
J Neuropsychiatry Clin Neurosci 17:489-495, Wall,C.A.,et al, 2005
Transmissible Spongiform Encephalopathies
Lancet 363:51-61, Collins,S.J.,et al, 2004
Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion
Lancet 363:417-421,411, Llewelyn,C.A.,et al, 2004
Preclinical vCJD After Blood Transfusion in a PRNP Codon 129 Heterozygous Patient
Lancet 364:527-529, Peden,A.H.,et al, 2004
Sporadic Creutzfeldt-Jakob Disease and Surgery
Neurol 59:543-548, Ward,H.J.T.,et al, 2002
14-3-3 Protein Cerebrspinal Fluid Detection in Human Growth Hormone-Treated Creutzfeldt-Jakob Disease Patients
Ann Neurol 49:257-260, Brandel,J.,et al, 2001
Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease
BMJ 322:841-844, Brown,P., 2001
14-3-3 Testing in Diagnosing Creutzfeldt-Jakob Disease
Neurol 55:514-516, Lemstra,A.W. et al, 2000
Iatrogenic Creutzfeldt-Jakob Disease at the Millenium
Neurol 55:1075-1081, Brown,P.,et al, 2000
Diffusion-Weighted MR Imaging of the Brain
Radiology 217:331-345, Schaefer,P.W.,et al, 2000
Risk of Transmission of Bovine Spongiform Encephalopathy to Humans in the United States, Report of the Council on Scientific Affairs
JAMA 281:2330-2339, Tan,L.,et al, 1999
Variant Creutzfeldt-Jakob Disease
Lancet 354:317-323, Collinge,J., 1999